Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Changes in breast cancer management

NCRI 2011

Published: 11 Nov 2011

Views: 4215

Rating:

Save

Prof David Cameron - Edinburgh Cancer Research Centre, UK

Speaking about his session at the National Cancer Research Institutes cancer conference, Prof David Cameron presented a challenge to his audience asking them how researchers and clinicians can use pathological and molecular insights to better utilise current treatment.

Currently predictions are made about the side effects of radiotherapy. In the future oncologists hope to understand better why some patients get toxicity later than others. In the long term, Dr Cameron hopes that the ability to analyse and evaluate on going treatment and then alter treatment, if needed, will soon develop.

Categories:
Breast
Biology
Radiotherapy

Related Videos

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy

Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines

Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy ( Dr Angeli Andrea Cocos-Alcantara - The Medical City, Pasig, Philippines )

Myeloma treatment and prognosis

Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India

Myeloma treatment and prognosis ( Dr Maitreyyee Bhattacharyya - Institute of Hematology and Transfusion Medicine, Kolkata, India )

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy

Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA

Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy ( Dr Julia Wong - Dana-Farber Brigham Cancer Center, Boston, USA )

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German

TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, German )

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )

The use of IORT at Universitätsmedizin Mannheim hospital

Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany

The use of IORT at Universitätsmedizin Mannheim hospital ( Dr Elena Sperk - Universitätsmedizin Mannheim, Mannheim, Germany )

Breast and emerging indications for IORT

Dr David Martinez Perez - AUNA, Lima, Peru

Breast and emerging indications for IORT ( Dr David Martinez Perez - AUNA, Lima, Peru )

The advantages of IORT for early breast cancer treatment

Dr David Martinez Perez - AUNA, Lima, Peru

The advantages of IORT for early breast cancer treatment ( Dr David Martinez Perez - AUNA, Lima, Peru )

The pros and cons of breast IORT and ultra hypofractionation (FR)

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

$The pros and cons of breast IORT and ultra hypofractionation (FR) ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )$

More from ecancer